We have shown that ER-negative and invasive human breast cancer cell lines MDA-MB-468 and MDA-MB-231 have constitutively higher mitogen activated protein kinase (ERK1&2/MAPK) when compared to the ERpositive and non-invasive MCF-7 human breast cancer cells. In MCF-7 cells, TGFa stimulation induced only transient MAPK activation, leading to a transient increase in cell migration. However, MDA 231 and MDA 468 cells, TGFa stimulation induced sustained MAPK activation, which correlated with enhanced cell motility and in vitro invasion. Serum stimulation activates ERK/MAPK activity persistently in both ER-positive and ER-negative breast cancer cells, leading to enhanced and sustained cell migration. Inhibition of MAPK activation by anti-sense MEK expression in MDA-MB-468 cells signi®cantly inhibits cell migration and in vitro invasion. In contrast, MCF-7 cells expressing constitutively activated MEK show a signi®cant increase in MAPK activity and cell migration, but this failed to enhance in vitro invasion. The kinetic pro®les of MAPK activation and inhibition show a relationship between the duration and magnitude of MAPK activation and cell migration in both ER-positive and ER-negative human breast cancer cells. These studies show that cell motility is modulated by the magnitude and the duration of MAPK activation; but increased activation of MAPK may not be sucient to allow in vitro invasion in noninvasive MCF-7 breast cancer cells. Oncogene (2001) 20, 4209 ± 4218.
Introduction
The MAP kinase cascade is one of the most characterized signaling pathways that connects dierent types of membrane receptors to the nucleus after mitogenic stimulation or dierentiation (Cobb and Goldsmith, 1995; Seger et al., 1995) . Signaling molecules in the MAPK cascade relay, amplify and integrate diverse signals, allowing the cells to coordinate a wide variety of cellular functions. These include proliferation, dierentiation, development, in¯ammatory response, apoptosis and cell migration (Marshall, 1994; Nishida and Gotoh, 1993) . Regulated cell migration is physiologically important for embryonic development, wound healing, and immunologic responses associated with in¯ammation. Moreover, unregulated migration is a central feature of some pathological states, most notably tumor invasion and metastasis.
The progression from a non-invasive primary tumor into metastatic disease can be described as discreet steps. These include the attachment to and degradation of the basement membrane, migration through and degradation of the extracellular matrix (ECM) components, intravasation and travel through the blood into distal sites, or travel through the lymphatic system, extravasation and growth in the distal site (Friedl et al., 1995) . The mechanism behind the conversion of a cell from non-invasive to invasive is poorly understood, but many factors seem to in¯uence this process. The key to understanding this progression is to study alterations in cellular signaling that contribute to the progression of the disease. In order for tumors to become invasive, the cell(s) must have the ability to degrade surrounding tissue and stroma and migrate into the surrounding tissue. Eliminating either protease secretion or cellular migration will disrupt the tumor's ability to invade. Thus, blocking either one is a suitable target to eliminate tumor cell invasion.
Previous studies show that cells can be stimulated to move towards soluble factors (chemotaxis) including growth factors, such as epidermal growth factor (EGF) (Price et al., 1996) , Insulin-like growth factor 1 (IGF-1) (Doerr and Jones, 1996) , Keratinocyte growth factor (KGF) (Sato et al., 1995) etc. However, since the binding of a growth factor to its receptor results in the activation of multiple signaling pathways, the precise signaling molecule(s) that regulate cell motility is poorly understood at this time. Growth factors such as EGF have the capability of activating multiple pathways by binding dierent adapter proteins. For example, binding of GRB2 to phosphorylated EGFR results in activation of G-proteins such as Ras and subsequent activation of the MAPK pathway (Xie et al., 1998) . Alternatively, SH2 domain binding proteins may result in the activation of the PI3K and PLC-g pathways (Xie et al., 1998) . Because of the numerous pathways that converge at MAPK in the growth factor signaling cascade are involved in cell motility and protease secretion, MAPK is thought to be one of the key regulators of these processes.
The dierences in the capacity of these growth factors to stimulate the cellular properties associated with cell growth and invasion has lead to comparative studies in an attempt to delineate the growth factordependent regulatory mechanisms that drive these dierences. These studies have provided evidence that certain receptor kinases such as EGFR, ERB2, PDGF and others are involved in tumor development (Heldin and Ostman, 1996; McCawley et al., 1999; Reddy et al., 1999b) . These growth factors have been shown to stimulate cell migration by activating receptor tyrosine kinase activity, leading to activation of the Ras/ MAPK signal pathways (Hartmann et al., 1994; Klemke et al., 1997) . These studies all show varying intrinsic ability of each dierent growth factor to activate MAPK, which correlates with dierential ability of these growth factors to regulate cell motility. Recent studies suggests that the dierences in the properties of these transmitted signals stimulated by dierent growth factors in the same cells may determine whether these cells proliferate, dierentiate or invade (Klemke et al., 1997; McCawley et al., 1999; Zeigler et al., 1999) . It has been shown that these dierent growth factors modulate MAPK activation in terms of magnitude (how much active MAPK at a given time) and duration (how long MAPK is active in the cell).
Studies using MAPK signaling pathway inhibitors, such as the MEK inhibitor PD98059, have established a role for the MAPK signaling pathway in regulating cell motilty (Klemke et al., 1997; Rigot et al., 1998; Nguyen et al., 1999) . However, regulation of cell motility by a single growth factor such as EGF may involve multiple pathways such as PLC-g, PKC, and PI3-K (Rigot et al., 1998; Potempa and Ridley, 1998; Chen et al., 1996) . It is not yet clear how MAPK modulates cell motility as an integrator of multiple and diverse growth factor signaling pathways. It is our hypothesis that MAPK activity has a proportional eect on modulating cell motility. In our study, we show that both magnitude and duration of MAPK modulate cell motility as a function of the total amount, or integral, of MAPK activity. This provides a mechanism by which multiple upstream signaling pathways are able to converge on MAPK, and modulate cell motility through MAPK activation. This study provides insight into one of the mechanisms by which human breast cancer cells may enhance cell motility and invasion through growth factor activation of MAPK.
Results
Prolonged MAPK activation regulates cell migration in human breast cancer cells TGFa has been reported to stimulate cell migration of many normal and tumorigenic cells (Manske and Bade, 1994) . To examine a potential role of MAPK in cell migration, we examined the level and duration of MAPK activation in ER-negative and invasive MDA-MB-468, MDA-MB-231 human breast cancer cells and ER-positive and non-invasive MCF-7 cells in the presence of TGFa. Time course analysis for ERK/ MAPK activation was performed to determine if dierences exist in level and duration of MAPK activation in ER-negative and ER-positive human breast cancer cells. In ER-negative MDA-MB-468 and MDA-MB-231 cells, TGFa (100 ng/ml) induced sustained MAPK activation up to 8 h ( Figure 1a ). This prolonged MAPK activation correlates with a *®ve-fold increase in cell motility at 4 h compared to unstimulated cells. TGFa stimulation of ER-positive MCF-7 cells also showed a transient MAPK activation (up to 2 h) and a ®vefold increase of cell motility by 4 h (Figure 1b) . However, the motility seen in ERnegative MDA-MB-468 and MDA-MB-231 cells is nearly 3.5-fold more than the motility seen in MCF-7 cells (Figure 1b) . We also found that MDA-MB-468 and MDA-MB-231 cells continued to migrate up to 8 h in the presence of TGFa stimulation. In contrast, MCF-7 cells only showed migration up to 4 h and then subsided. These results indicate that duration of MAPK activation may play a major role in cell migration.
Additionally, we have evaluated total MAPK activity in MDA cell lines compared to MCF-7 cells. This integrated MAPK activity is determined by segregating the time points into discrete functions of MAPK activity. This value of the integral is found by multiplying by the increase in MAPK activity compared to the control by the duration of that activity; then each value is added up to obtain a semiquantitative value for the total MAPK activity (see Materials and methods). This integral of total MAPK activation shows that in MDA-MB-231 and MDA-MB-468 cells, overall MAPK activity was nearly twofold in compared to MCF-7 cells (Figure 1c ). This correlates with increased amount and duration of motility seen in these cells.
To verify if the above mechanism is only speci®c for TGFa stimulation, or if other stimulants work through a similar mechanism, we serum starved the cells for 24 h and then stimulated them with 10% serum (which contains multiple growth factors and hormones). Serum stimulation of MCF-7 cells resulted in longer period of MAPK activation when compared to TGFa stimulation (Figure 2a) . Consequently, serum-stimulation of MCF-7 cells showed a *twofold increase in cell migration when compared to TGFa treated cells at 8 h (Figure 2b ). When total MAPK activity is integrated, serum stimulated MCF-7 cells show over a ®vefold increase in total MAPK activity over TGFa stimulated cells (as a function of the longer duration of MAPK activation). This correlates with the enhanced and sustained cell motility seen by 8 h (Figure 2c ). In MDA-MB-468 cells, cell motility only increased by *30% when compared to TGFa treated cells. This may be due to the observation that in these cells serum does not induce signi®cant activation of MAPK compared to TGFa alone. Consistent with the above data, these results show a correlation between duration of MAPK activation and cell migration.
MAPK activation is critical for cell migration and invasion in ER-negative breast cells
To further investigate the role of activated MAPK in cell motility and invasion, we used ER-negative MDA-MB-468 cells since they have high levels of MAPK activity. In these experiments, we stably expressed anti-sense MEK in MDA-MB-468 cells (three clones). As shown in Figure 3a ,b, anti-sense MEK expression shows a signi®cant reduction in mRNA and protein levels of MEK without aecting the MAPK protein levels when compared to control cells. A reduction in MEK protein, an upstream activator of MAPK, reduced the growth factor mediated signaling and MAPK activation. This lead to a 70 ± 80% reduction in cell motility and invasion when compared to wild type cells (Figures 3c and 4a ± b). Anti-sense MEK expression in MDA-MB-468 cells had no obvious eect on cell adhesion or spreading of these cells (data not shown). These ®ndings suggest MAPK activation plays a major role in cell motility and invasion; and disruption of MAPK signaling substantially impairs cell motility and invasion of human breast cancer cells.
MAPK activation is critical for cell migration but not sufficient to induce invasion in ER-positive breast cells
To further investigate the role of enhanced MEKsignaling on cell motility and invasion, we used ERpositive non-invasive MCF-7 cells since they showed low MAPK activity, cell migration and no invasion ( Figures 1, 2 and 4d ). Previously published data shows that ERK1 and ERK2 are speci®cally activated by MEK1 because of its ability to promote both threonine and tyrosine phosphorylation of these (Cowley et al., 1994; Zheng and Guan, 1994) . In addition, there is data from our group using SKBR-3 cells (Reddy et al., 1999b) and also other groups using keratinocytes suggesting growth factors that can induce sustained MAPK activation enhances cell migration and invasion (McCawley et al., 1999; Zeigler et al., 1999) . To test the hypothesis that MAPK activation enhances cell motility and invasion in non-invasive cells, we stably expressed a constitutively activated MEK1 in non-invasive MCF-7 cells (MEK/MCF-7 cells) and examined its eect on cell migratory and invasive properties. As shown in Figure 5a , upper panel, MEK/MFC-7 cells show a signi®cant increase in activated MAPK when compared to control cells. These MEK/MCF-7 clones showed a *2 ± 3-fold increase in cell motility compared to wild type MCF-7 cells (Figure 5b ). The use of MEK inhibitor PD98059 was able to abrogate this eect (Figure 5c ). In spite of increased cell migration due to enhanced activation of MAPK, there was no change in the invasive capability of MEK/MCF-7 cells when compared to parental cells (Figure 4a ). These studies demonstrate that MEK/ MAPK mediated signaling plays a major role in cell migration in MCF-7 cells, but may not be sucient to induce in vitro invasion.
The duration of MAPK activity correlates with the duration of cell migration
To directly test the role of duration of MAPK activation in cell migration, we examined whether inhibition of MAPK activation at dierent time points correlate with reduced cell migration. We stimulated MCF-7 and MDA-MB-468 cells to migrate in the presence of TGFa and then added MEK inhibitor PD 98059 at 2 and 4 h and counted the migrating cells at the 4 and 8 h time points. As shown in Figure 6 , addition of MEK inhibitor led to signi®cant reduction in MAPK activity; and this leads to inhibition of further cell migration. This suggests that continued MAPK activation is required for cell motility. This further con®rms our hypothesis that the duration of cell motility is dependent on the duration of MAPK activation.
Discussion
MAPK plays a pivotal role in cell proliferation, and its activity is regulated by diverse extracellular signals (Cobb and Goldsmith, 1995) . MAPK is regulated by reversible protein phosphorylation controlled by a family of dual speci®c protein kinases (MAPK kinase, or MEK), and a complex upstream cascade from tyrosine kinase-linked and G-protein-linked receptors (Cobb and Goldsmith, 1995) . In vivo analysis of MAPK expression in human breast tumors revealed hyper-expression of MAPK in primary tumors and in metastatic cells within involved lymph nodes of patients with breast cancer (Sivaraman et al., 1997) . In addition, it was shown that hyper-activation of MAPK may contribute to the neoplastic phenotype of low-grade and malignant gliomas (Mandell et al., 1998) . These studies implicate MAPK in the regulation of tumor development.
Epidermal growth factor (EGF) family members have been previously shown to stimulate migration of a number of cell types, yet the major step in signaling pathways that regulate growth factor-stimulated migration is poorly de®ned (Price et al., 1996) . For example, it has been shown that EGF-induced mitogenic cell responses in which the PLC gamma pathway stimulate cell motility, is distinct from the MAPK-dependent signaling pathway leading to disassembly and reorganization of cell-substratum adhesion and cell motility in ®broblasts (Xie et al., 1998) . In contrast, there is data to show that EGF-induced Raf activity may inhibit EGF-induced cell motility in rat embryo ®broblasts (Slack et al., 1999) . This suggests that mechanisms responsible for speci®city of response may vary depending on cell type and that there are multiple and distinct signaling mechanisms regulating cell motility.
In normal cells, conditional MAPK activation is important in gene regulation, promoting G1 cell cycle progression before DNA replication (Gotoh et al., 1999) . Many oncogenes, such as Ras, are able to constitutively activate the MAPK pathway, but it is this inappropriate activation of MAPK that may mediate the transformation to invasive phenotype (Lewis et al., 1998) . There are several possible mechanisms by which prolonged activation of ERK/ MAPK signaling may be achieved by a cell. These include over-expression of cell surface receptors (Traverse et al., 1994) , or defective regulation of protein kinase activation or protein phosphatases (Hunter, 1995) . This increase in MAPK activity in the MDA-MB-231 and MDA-MB-468 cell lines may be due to over-expression of EGF receptor family members, or mutant oncogenes such as ras (Fan et al., 1998; Gilhooly and Rose, 1999; Prasad and Brandt, 1997) . The dierences in number of EGF-R in these cells may be responsible for the increase of growth factor induced MAPK activation (Rajkumar and Gullick, 1994; Reddy et al., 1999a). Additionally, several studies have shown that phosphatases play a critical role in regulating the activity of MAPK. The dierences in phosphatase activity between cell lines with dierent phenotypic traits (malignant vs non-malignant) may in part explain the dierences seen in kinase activity and behavior of these cells (Gopalakrishna et al., 1999; Mishra and Hamburger, 1993; Ward et al., 1994) . The dierences in MAPK activation in these cells may be due a reduction in phosphatase activity; or more ecient phosphatase activity in MCF-7 cells compared to MDA cells. We were able to show this concept by using sodium orthovanadate, a potent phosphatase inhibitor, in MCF-7 cells, that the presence of active MAPK could be prolonged to resemble the MAPK activation pattern seen in MDA-MB-231 and MDA-MB-468 cell lines (data not shown). It is our opinion that these dierences in MAPK activation is critical for the phenotypic dierences seen between these ER positive and ER negative (non-invasive vs invasive, respectably) cells in vivo and in vitro.
As shown in Figure 1a , the MDA-MB-231 and MDA-MB-468 cell lines show a higher and sustained MAPK activation in response to TGFa stimulation, which correlates with enhanced cell migration and in vitro invasion. This observation is in agreement with our hypothesis that elevated and sustained MAPK signaling contributes to the invasive phenotype by increasing cell motility. Figure 2a shows that under serum stimulated conditions, MAPK activity in MCF-7 cells is persistent, and this correlates with continued cell motility in contrast to TGFa treatment (Figures 1b  and 2b ). As shown in Figure 1b , the amount of cell motility seen in MCF-7 after 4 h of TGFa stimulation (where no MAPK is activated) is not statistically signi®cant, and the absence of active MAPK in the cells correlates with the inability of the cells to migrate.
This concept is con®rmed in Figure 5 , when PD98059 is used to block MAPK activation after serum stimulation. After adding the MEK inhibitor PD98059 at either 2 or 4 h of serum stimulation, motility is stopped shortly thereafter. At the time points where no PD98059 is added, motility progresses; but as soon as PD98059 is added, motility is reduced to basal levels. This shows the requirement for maintaining MAPK activity during cell motility. This also indicates that regardless of the dierences in the cell lines or the type of stimulus given, there is a correlation between the presence of active MAPK and the ability of the cell to migrate. These observations provide a role for MAPK as the key modulator of cell motility. This is in agreement with previously published data, which shows that the duration of MAPK activation induced by dierent growth factors elicits dierent responses in keratinocytes (McCawley et al., 1999; Zeigler et al., 1999) . As mentioned previously, there is signi®cant dierence in the type of MAPK activation seen in the MCF-7 cell line compared to MDA-MB-231 and MDA-MB-468 cells using TGFa. A very transient (less than 2 h) nearly 10-fold increase in MAPK activation is seen in MCF-7 cells, in contrast to MDA-MB-231 and MDA-MB-468 cells, which show a 3-and 2-fold increase in MAPK activation respectively (Figure 1a) . However, MDA-MB-231 and MDA-MB-468 cell lines maintain at least a twofold increase in MAPK activity over the control during the time course observed. As shown in Figure 1d , total MAPK activity was integrated by segregating the time points into discrete functions of MAPK activity. This integral of total MAPK activation shows that despite the large but short-lived induction of MAPK activity in MCF-7 cells, the longer, more sustained MAPK activity in the MDA cell lines is considerably more. This observation correlates with the migration data observed in Figure  1 , where the MDA cell lines have increased and sustained motility in comparison to MCF-7 cells. As well, as shown in Figure 2 , when MCF-7 cells are stimulated with serum, MAPK activity is sustained, and the integral of MAPK activation approaches that of MDA-MB-231 and MDA-MB-468. Likewise, in these conditions cell motility is increased and sustained in contrast to TGFa. Thus, two dimensions of MAPK activity; the magnitude of activation, and the duration of activation; must be considered when determining the modulation of cell motility by MAPK.
To investigate how the magnitude of MAPK activation plays a role in cell motility and invasion, we developed clones that express anti-sense MEK in ER-negative and invasive MDA-MB-468 cells (Shao et al., 1998) , which have constitutively high MAPK activity (Figure 4) . Anti-sense MEK expressing MDA-MB-468 cells showed a signi®cant reduction in MEK protein, leading to inhibition of TGFa and serum-induced MAPK activation. This inhibition of MAPK activity by anti-sense expression led to signi®cant reduction in cell motility and in vitro invasion. This data demonstrates that by blocking the MAPK signal transduction pathway, cell motility and invasion can be blocked in malignant tumor cells.
Conversely, increased MAPK activation leads to enhanced cell migration in non-invasive MCF-7 cells. To show this, we used constitutively activated MEK transformed MCF-7 (MEK/MCF-7) cells. MEK/MCF-7 cells showed a signi®cant increase in MAPK activation (3.6 ± 5-fold), leading to enhanced cell migration. However, this enhanced MAPK activation failed to enhance invasion. We feel this may be due to an inherent lack of ability of these cells to invade. Cell motility and protease secretion are complex processes, with cell motility involving many cytoskeletal changes and alterations cell adhesion proteins such as cadherins and integrins. In addition, protease secretion depends on induction of protease genes controlled by a host of transcription factors as well as a wide variety of proteases used to degrade the extracellular matrix. Since cell invasion requires both protease secretion and cell motility, a reduction in either one will have a direct impact on the cell's ability to invade. However, increasing one aspect of this process, cell motility, is not sucient to induce invasive capability in noninvasive MCF-7 cells.
To further test our hypothesis that the presence of activated MAPK is required for maintaining cell migration, we inhibited MAPK activation by MEK1 inhibitor PD 98059 at dierent time points during cell migration ( Figure 5 ). Addition of MEK inhibitor leads to signi®cant reduction in MAPK activity, and this led to inhibition of cell migration when compared to untreated cells. This data shows a good correlation the presence of activated MAPK and the ability of the cells to migrate. In contrast to other studies that inhibit initial MAPK activation using PD98059, in our study we allowed initial activation of MAPK, followed by blocking further activation of MAPK by the addition of PD98059. This study shows that not only must active MAPK be maintained during cell motility, but that continuing activation of MAPK is necessary. This result has provided de®nitive link between duration of MAPK activation and the duration of cell migration in both non-invasive and invasive cells.
In this study, ®rst we provided several lines of evidence to show that the duration of MAPK activation (sustained vs transient) of MAPK (ERK1 and ERK2) signaling may be the underlying mechanism to account for dierences in the ER-positive MCF-7 and ER-negative MDA-MB-468 human breast cancer cells' ability to migrate. Second, we showed that the magnitude of MAPK activation is important in modulating cell motility in these cells. Both of these factors (magnitude and duration) could be described in terms of integrating MAPK activity and correlating it with motility. We have also showed that blocking cell motility by inhibiting MAPK activation is sucient to signi®cantly reduce in vitro invasion in MDA 468 cells. Finally, we showed that hyperactivation of MAPK is not sucient to induce in vitro invasion in the non-invasive MCF-7 cell line, indicating that MAPK is required, but not sucient for in vitro invasion. In summary, we have established the ERK/MAPK pathway as the major signaling molecule in the process of regulating growth factor induced cell motility and invasion. These studies provide a substantial role for the magnitude and duration of activation of ERK/MAPK as an important sensor in regulating cell motility and invasion in breast cancer cells.
Materials and methods

Cell lines and reagents
MCF-7 and MDA-MB 468 cells were obtained from ATCC (Rockville, MD, USA) and culture conditions have been described brie¯y. All breast cancer cells were cultured in DMEM (Life Technologies, Gaithersburg, MD, USA), supplemented with 5 ± 10% FCS (Life Technologies) and 10% insulin (Life Technologies) as described previously (Reddy et al., 1999a) . All cell lines were routinely tested for mycroplasma contamination and found to be negative. Phosphorylated MAPK (mouse monoclonal) was obtained from New England Biolabs and total MAPK (rabbit polyclonal) was obtained from Zymed. TGFa was purchased from R&D systems, collagen was purchased from BectonDickinson. PD98059 was obtained from Calbiochem and dissolved in DMSO. The total ®nal concentration of DMSO did not exceed 0.1% in any experiment.
Constructs
MEK cDNA was a gift from Dr Guan (Dept. of Biochemistry, University of Michigan, Ann Arbor, MI, USA). MEK cDNA was subcloned in the wrong orientation into pcDNA-3 expression vector, which utilizes a cytomegalovirus promoter to drive expression protein.
Constitutively active MEK cDNA was derived by alteration of phosphorylation sites (Ser-218 and Ser-222) and deleting residues 32 ± 51 from NH 2 -terminal was a generous gift from Dr Ahn (Univ. Colorado, Boulder, CO, USA) (Mansour et al., 1994) . The expression plasmid vector was used as a transfection control. Stable cells lines were developed by transfecting cells with 1 ± 5 mg of DNA using electroporation. In brief: 60 ± 80% con¯uent cells were harvested by trypsizing, and resuspending them in complete medium at 1610 7 cells/ml. In a 0.4-cm cuvette, mix 0.4 ml of cells are mixed with 10 ng DNA and electroporate in Bio-Rad Gene Pulsar at 950 mF and 0.22 kV/cm (t=20 ± 30 ms). Cells were plated in 10-cm culture dishes containing 10 ml of appropriate complete medium and allowed to divide twice (typically occurs in *2 ± 3 days), then split into 10 ± 20, 10-cm dishes containing appropriate selection medium.
Western blot analysis of MAPK
To con®rm whether MAPK was activated or suppressed in cells transfected with activated MEK or anti-sense expressing vector, cells were plated in six-well dishes in regular medium with serum. When they are 60 ± 80% con¯uent, they are serum-starved for 24 h, then treated with TGFa and/or PD98059 or with vehicle. Cells were then washed with ice-cold phosphate-buered saline and scraped into lysis buer (50 mM Tris-Hcl, pH 7.6, 100 mM NaCl, 2 mM EDTA, 1% NP-40, 1 mM Orthovanadate, 0.5% sodium deoxycholate, 10 mg/ml leupeptin, 2 mM phenylmethylsulfonyl¯uoride, 10 mg/ml aprotinin). After removal of cell debris by centrifugation (14 000 g, 30 min), protein was estimated. Equal amount of protein from dierent groups were subjected to SDS ± PAGE and transferred to a membrane. Phosphorylated MAPK and total MAPK were assayed as described previously (Kondapaka et al., 1997) . In brief the activated proteins were detected by immunoblot analysis with the phospho-MAPK. The same membrane was striped and probed with total MAPK antibody.
Quantification of MAPK activity
The integral of MAPK activity is de®ned as a semiquantitative function to describe the contributions of both the duration and magnitude of MAPK activation. This is useful in determining the contribution of these two aspects in the regulation of cell motility. The normalized (to total MAPK) values of phosphorylated MAPK in the cell during stimulation with TGFa or serum are assigned a value of induction compared to basal (unstimulated levels) within a cell line (P). These values are multiplied by the factor of the time period for which they were determined (T). Since the amount of phosphorylated MAPK in the cell is a dynamic process dependant on phosphorylation of inactive MAPK by upstream regulators and dephosphorylation by speci®c phosphatases, the value assigned is not a purely quantitative value, but rather a representation of the MAPK activity during that time period. Then, all of these values are added to obtain a ®nal arbitrary number that re¯ects the total amount of active MAPK in the cell during the time period analysed (I). The formula can be described as: I=T1(P1)+T2(P2)+T3(P3)+T4(P4); where T1 is the time period of 15 min (0.25); T2 is (2 ± 0.25 h=1.75); T3 is (4 ± 2 h=2); and T4 is (8 ± 4 h=4).
Northern hybridization
Total RNA for the Northern analyses was prepared as described previously (Chomczynski and Sacchi, 1987) . RNA concentration was determined by measuring absorbance at 260/280 nm. The concentration and integrity of RNA preparations were con®rmed by electrophoresis in formaldehyde gels with ethidium bromide staining. RNA was electrophoresed into formaldehyde containing 1.0% agarose gel and blotted onto a nitrocellulose coated nylon membrane. The nylon membrane ®lters were hybridized with a 32 Plabeled cDNA in Rapid-hyb buer, according to the manufacturer's protocol (Amersham, Arlington Heights, IL, USA). Relative levels of speci®c mRNA were quanti®ed by densitometry.
Migration assays
To study the migration of MEK-expressing cells, Transwell cell culture inserts (6.5 mm, 8.0-mm pores) (Falcon) were coated on the backside with 500 ml of 10 mg/ml type I collagen for 2 h at 378 Cells were pretreated for 30 min with 40 mm PD98059 or untreated cells are then added to the top chamber in serum free medium. TGFa was added to some of the transwell cell culture inserts. The bottom chamber always contained 20% FCS, providing a chemotactic gradient and ®nal concentration of 10% FCS in the well. After terminating a study, cells were removed from the top surface of each membrane using cotton swab. Cells that penetrated to the underside surfaces of the membrane were ®xed and stained with HEMA3 staining kit (Fisher Scienti®c) and counted under the microscope.
